Clinical and molecular characteristics of Japanese Gaucher disease

Neurochemical Research

Volumn 24, Issue 2, 1999, Pages 207-211

  Eto, Yoshikatsu ^a   Ida, Hiroyuki ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Japanese Gaucher disease; Neurological disease

Indexed keywords

ADULT; ALLELE; ARTICLE; BONE DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FATALITY; GAUCHER DISEASE; GENOTYPE; HUMAN; JAPAN; JEW; MAJOR CLINICAL STUDY; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE; SINGLE STRAND CONFORMATION POLYMORPHISM; SPLENECTOMY;

AGE OF ONSET; BONE AND BONES; CHILD, PRESCHOOL; COHORT STUDIES; GAUCHER DISEASE; GENOTYPE; HUMANS; INFANT; JAPAN; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SPLENECTOMY;

HYDROPS;

EID: 0032956999     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022553819241     Document Type: Article

References (27)

1. Kawame H. and Eto Y. 1991. A new missense mutation in the glucocerebrosidase gene responsible for neuropathic Gaucher in Japanese. Amer. J. Human Genet. 49:1378-1380.
2. Ida H., Iwasawa K., Kawame H., Rennert. OM., Maekawa K., and Eto Y. 1995. Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients; absence of the common Jewish 84GG and 1226G mutation. Hum. Genet. 95:717-720.
3. Ida H. Rennert OM., Kawame H, Maekawa K., and Eto Y. 1996. Mutation screening of 17 Japanese patients with neuropathic Gaucher disease. Hum. Genet. 98: 167-171.
4. Ida H., Rennert OM., Kawame H., Maekawa K., Eto Y. 1997. Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations. J. Inher. Metab. Dis. 20:67-73.
5. Horowitz M., M., Tzuri G., Eyal N., Berebi A., Kolodny EH., Brady RO., Barton NW. et al. 1993. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients. Am. J. Hum. Genet. 53:921-930.
6. Grabowski G. A. 1995. Gaucher disease in Metabolic Basis of Inherited Disease (Scriver CR., Beaudet AL., Sly WS., Valle D, eds) 6th ed. McGraw Hill, NY 376-440.
7. Dreborg S, Erikson A., Hagberg B. 1980. Gaucher disease-Norrbottnian type I. General clinical description. Eur. J. Pediatr. 133:107-118.
8. Dahl N., Langestrom M., Erikson A., Petterson U. 1990. Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of glucocerebrosidase gene. Am. J. Hum. Genet. 47: 275-278.
9. Ida H, Rennert OM, Ito T., Maekawa K., Eto Y. 1988. Type 1 Gaucher disease: Phenotypic expression and natural history in Japanese patients, Blood Cells, Mol. and Dis. 24:73-81.
10. Ida H, Rennert OM., Yabe H. Kato S, Ueda T. Maekawa K, Eto Y. 1997. Skeletal complications of type 1 Gaucher disease in Japanese patients, manuscript in preparation.
11. Ida H, Rennert OW., Ito T, Maekawa K, and Eto Y. 1996. Clinical and genetic studies of five fatal cases of Japanese Gaucher disease type I. Acta. Pediatr. Jpn. 38:233-236.
12. Tsuji S, Martin BM., Barranger JA. et al. 1988. Genetic heterogeneity in type 1 Gaucher disease: Multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc. Natl. Acad. Sci. USA 85:2349-2352.
13. Latham T, Grabowski GA., Theophilus BD. M, Smith FI. 1990. Complex alleles of the acid β-glucosidase gene in Gaucher disease. Am. J. Hum. Genet. 47:79-86.
14. Masuno M, Tomatsu S, Sukegawa K, Orii T. 1991. Non-existence of a tight association between a 444 leucine to proline mutation and phenotypes of Gaucher disease: high frequency of a Ncil polymorphism in the non-neuronopathic form. Hum. Genet. 84:203-206.
15. Beutler E., Gelbart T., Kuhl W., Sorge J. and West C. 1991. Identification of the second common Jewish Gaucher disease mutation makes possible population based screening for the heterozygous state. Proc. Natl. Acad. Sci., USA 88:10544-10547.
16. Beutler E. 1993. Gaucher disease as a paradigm of current issues regarding single gene mutations of humans. Proc. Natl. Acad. Sci. USA 90:5384-5390.
17. Grace ME., Desnick RJ., Pastores GM. 1997. Identification of acid glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients. Clin. Invest. 99(10): 2530-2537.
18. Grabowski GA. and Horowitz M. 1997. Gaucher disease: molecular, genetic and enzymological aspects. Bailer's Clin. Haematol. 10(4):635-656.
19. Kawame H., Hasegawa Y. and Eto Y. 1992. Rapid identification of mutations in the glucocerebrosidase gene of Gaucher disease patients by analysis of single strand conformation polymorphism. Human Genetics. 90:294-296.
20. Zimran A., Sorge J. Gross E., et al. Prediction of severity of Gaucher disease by identification of mutations at DNA level. Lancet. ii, 349-352.
21. Sidransky E, Scerer DM., Ginns E. I. 1992. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebroside gene. Pediatr. Res. 32:494-498.
22. Tayebi N., Cushner SR., Kleijer W., et al. 1997. Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene. Am. J. Med. Genet. 73(1):41-47.
23. Tybulewicz VL., Tremblay ML., LaMarca ME., et al. 1992. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357(6377):407-410.
24. Abrahamov A, Elstein D, Gross-Tsur V et al. 1995. Gaucher's disease variant characterized by progressive calcification of heart valves and unique genotype. Lancet. 346:1000-1003.
25. Chabas A, Cormand B, Grinberg D, et al. 1995. Unusual expression of Gaucher's disease: cardiovascular calcification in three sibs homozygous for the D409H mutation. J. Med. Genet. 32:740-742.
26. Uyama E., Uchino M., Ida H., Eto Y. and Owada M. 1997. D409H/D409H genotype in Gaucher-like disease. J. Med. Genetics 34:175.
27. Patterson MC., Horowitz M, Abel R.B., et al. 1993. Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher disease. Neurology 43:1993-1997.